Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
Not Applicable
Recruiting
- Conditions
- CancerMalignant NeoplasmMalignancy
- Registration Number
- NCT05886764
- Lead Sponsor
- University of Chicago
- Brief Summary
This trial will study different outreach methods to assess impact on enrollment of underrepresented minorities (specifically African Americans) to early phase cancer clinical treatment trials. Both patients and providers (those seeing enrolled patients) will be enrolled and receive the study interventions or no intervention (control arm).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percentage of patients that enroll to early phase cancer treatment clinical trials. within 2 months of randomization
- Secondary Outcome Measures
Name Time Method Number of successfully completed outreach efforts after 30 participants are enrolled to each of arms 2 and 3 Percent change in number of African Americans that enroll to cancer clinical trials 2 years after study start Percentage of patients that enroll to early phase cancer treatment clinical trials post intervention. 2 years from randomization
Trial Locations
- Locations (1)
University of Chicago Medicine Comprehensive Cancer Center
🇺🇸Chicago, Illinois, United States
University of Chicago Medicine Comprehensive Cancer Center🇺🇸Chicago, Illinois, United States